Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

1.1K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

1.2K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.2K
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

869
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
869
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

821
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
821
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

710
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
710
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

940
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
940

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient partnership model in rare and complex rheumatological conditions: research and beyond in European Reference Network ReCONNET.

The Lancet. Rheumatology·2026
Same author

Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus.

Scientific reports·2025
Same author

<i>Hydatigera parva</i> population genetics in Iberian rodents provides insights into its introduction from Africa.

Parasitology·2025
Same author

Association of variants in AGTR1, ACE, MTHFR genes with microalbuminuria and risk factors for the onset of diabetic nephropathy in adolescents with type 1 diabetes in the population of Serbia.

PloS one·2024
Same author

Systemic sclerosis and environment: an intriguing and still debated association.

Clinical and experimental rheumatology·2024
Same author

Can Combination Therapy with Endothelin Receptor Antagonist and PDE5 Inhibitors Prevent Echocardiographic Findings Suspicious for Pulmonary Arterial Hypertension? Description of a Real-Life Case Series.

Diagnostics (Basel, Switzerland)·2024

Related Experiment Video

Updated: Apr 17, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.2K

Systemic sclerosis: clinical manifestations.

Jelena Blagojevic, Marco Matucci-Cerinic1

  • 1Department of Biomedicine, Division of Rheumatology AOUC, Denothe Centre, University of Florence, viale Pieraccini 18, 50139 Firenze, Italy.

Current Rheumatology Reviews
|February 19, 2015
PubMed
Summary
This summary is machine-generated.

Systemic sclerosis (SSc) is a severe autoimmune disease affecting multiple organs. Early detection and prompt treatment are crucial for managing SSc complications, despite recent therapeutic advances.

More Related Videos

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from S&#233;zary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.5K
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

1.6K

Related Experiment Videos

Last Updated: Apr 17, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.2K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from S&#233;zary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.5K
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

1.6K

Area of Science:

  • Rheumatology and Immunology
  • Autoimmune Diseases
  • Fibrotic and Inflammatory Disorders

Background:

  • Systemic sclerosis (SSc) is a severe, heterogeneous autoimmune disease.
  • It involves microvascular, inflammatory, and fibrotic changes affecting skin and internal organs.
  • Key affected organs include the lungs, heart, kidneys, and gastrointestinal tract.

Purpose of the Study:

  • To summarize the current understanding of Systemic Sclerosis.
  • To highlight the heterogeneity of clinical manifestations.
  • To emphasize the need for improved management strategies.

Main Methods:

  • Review of current literature on Systemic Sclerosis.
  • Analysis of disease manifestations and treatment progress.
  • Assessment of challenges in managing organ impairment.

Main Results:

  • Systemic sclerosis presents with diverse clinical features due to vascular, inflammatory, and fibrotic processes.
  • While treatments for renal and pulmonary hypertension complications have improved, overall prognosis remains poor.
  • Significant efforts are still required for early detection and timely intervention.

Conclusions:

  • Systemic sclerosis necessitates advanced management strategies for organ-specific complications.
  • Early diagnosis and prompt treatment are vital to prevent severe disease progression.
  • Continued research is essential to improve patient outcomes in Systemic Sclerosis.